EPS beat and guidance rose, but Marketplace weakness worsened

The quarter beat a lowered bar. Adjusted EPS came in at $1.51 versus a published consensus near $1.37, while revenue of $10.87 billion was roughly in line with or slightly above published estimates. The beat was helped by better-than-expected Medicare performance, but it was not a clean operational upside story because the consolidated medical care ratio rose to 92.2% from 90.4% a year earlier. (Financial Highlights)

The guidance increase is real, but narrower than the headline suggests. Full-year adjusted EPS guidance rose by $0.25 to at least $5.25, driven by stronger first-half Medicaid results. (2026 Guidance) However, management simultaneously reduced its Marketplace contribution by $1.50 per share and raised Medicare by an offsetting $1.50; excluding Marketplace, the guide would have risen to $6.75. (2026 Guidance) That makes the net upgrade modest rather than a broad-based earnings acceleration.

Marketplace is the clear deterioration. Marketplace MCR reached 88.9%, above the company’s expectations, versus 85.4% a year earlier, while Marketplace premium revenue fell to $628 million from $1.20 billion and membership declined to 283,000 from 655,000 at year-end 2025. (Segment results — Marketplace; Membership) Medicaid MCR also worsened to 92.7% from 91.3%, although management said it was in line with expectations; Medicare MCR improved relative to management’s expectations. (Segment results — Medicaid and Medicare)

The net read is a modest beat with a better floor, not a clean reset higher. The EPS surprise and $0.25 guidance lift are better than the market’s standing expectation, but the upside is largely Medicaid-driven and offset by sharper Marketplace pressure. Cash flow improved substantially to $788 million from a $112 million outflow, though management attributed much of the change to government receivable and payable timing rather than a durable earnings improvement. (Cash Flow statement)